Limited Period Offer:Be a PRO for 1 month @Rs49/-Multiple payment options available. Know More

Tika Utsav: 27.69 lakh COVID-19 vaccine doses administered on Day 1

Of the more than 27 lakh vaccine doses administered on day one of Tika Utsav, over nine crore were first doses. With this, the number of vaccine beneficiaries aged above 60 years, who have got their first dose of coronavirus vaccine, crossed the four crore-mark.

April 11, 2021 / 10:44 PM IST
Representational image

Representational image

On the first day of the ‘Tika Utsav’ (special inoculation drive) launched by Prime Minister Narendra Modi on April 11, 27.69 lakh vaccine doses were administered till 8 pm, taking India’s cumulative COVID-19 vaccination coverage to over 10.4 crore doses.

Of the more than 27 lakh vaccine doses administered on day one of Tika Utsav, over nine crore were first doses. With this, the number of vaccine beneficiaries aged above 60 years, who have got their first dose of coronavirus vaccine, crossed the four crore-mark.

Prime Minister Narendra Modi inaugurated the Tika Utsav on April 11, saying it is the second big war on COVID-19. “We’re going to begin the ‘Tika Utsav’ today (Sunday). I urge my countrymen to abide by 4 things — assist those who need help getting inoculated, help people in COVID treatment, wear masks and motivate others, and if someone tests positive, create micro containment zone in the area,” he added.

Notably, India also began workplace vaccination from April 11.

Meanwhile, India added 1,52,879 fresh coronavirus infections in the past 24 hours, setting yet another one-day record as the country’s tally crossed 1.33 crore cases. India’s COVID-19 death toll reached 1.69 lakh on April 11 with 839 more deaths being added in the last 24 hours.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show
Follow our coverage of the coronavirus crisis here
Moneycontrol News
first published: Apr 11, 2021 10:44 pm

stay updated

Get Daily News on your Browser
Sections